Boston Bio Systems Ltd. - Research Center
531458 BOSTONBIO Group (X) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 18 |
Mar ' 17 |
Mar ' 16 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
| -1.10 |
-0.55 |
-0.40 |
-0.40 |
-0.40 |
Secured loans
Unsecured loans
Total
| 11.35 |
7.32 |
7.47 |
7.47 |
7.47 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
| 14.90 |
10.57 |
10.07 |
9.36 |
8.93 |
Less : current liabilities & provisions
Total net current assets
| 11.35 |
7.32 |
7.47 |
7.47 |
7.46 |
Miscellaneous expenses not written
Total
| 11.35 |
7.32 |
7.47 |
7.47 |
7.47 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
| 70.02 |
70.02 |
70.02 |
70.02 |
70.02 |